Drug Delivery Devices - NAFTA

NAFTA

Highlights

Revenue in the Drug Delivery Devices market market in North American Free Trade Agreement (NAFTA) is anticipated to attain US$16.14bn in 2024.
Revenue is projected to exhibit an annual growth rate (CAGR 2024-2029) of 4.67%, leading to a market volume of US$20.27bn by 2029.
In a global context, the majority of revenue is expected to be produced the United States, which is forecasted to generate US$15.01bn in 2024.
The United States is witnessing a surge in innovation within drug delivery devices, driven by increasing demand for personalized medicine and patient-centric solutions.

Market definitionIn-Scope/Out-of-scopeMarket structureReportsMethodology

The Drug Delivery Devices Market within the Medical Devices sector in NAFTA is experiencing mild growth, influenced by factors such as technological advancements, regulatory challenges, and increasing patient demand for efficient and personalized treatment options.

Customer preferences: In the Drug Delivery Devices Market within the Medical Devices sector in NAFTA, consumers are increasingly favoring innovative and user-friendly delivery systems that align with their active lifestyles. There is a notable trend towards personalized medicine, with patients showing a preference for devices that cater to their specific health needs and conditions. Additionally, the rise of e-commerce has made access to these devices more convenient, while an aging population is driving demand for portable and easy-to-use solutions for chronic disease management and adherence to treatment regimens.

Trends in the market: In the NAFTA region, the Drug Delivery Devices Market within the Medical Devices sector is experiencing a shift towards smart, connected devices that enhance patient engagement and adherence. This trend reflects a growing demand for integrated solutions that combine drug delivery with real-time monitoring capabilities, allowing for tailored treatment regimens. Additionally, regulatory advancements are facilitating faster approvals for innovative products. As e-commerce continues to expand, stakeholders must prioritize user experience and accessibility, while also addressing the need for education on device utilization to optimize health outcomes.

Local special circumstances: In Canada, the Drug Delivery Devices Market is shaped by a strong emphasis on patient-centered care and innovation in healthcare technology. The country’s diverse population drives the demand for personalized drug delivery solutions that cater to varying health needs. In Mexico, cultural attitudes towards traditional medicine influence the acceptance of advanced drug delivery devices, necessitating educational efforts to promote understanding and trust. Additionally, U.S. regulatory frameworks enhance collaboration across borders, streamlining the introduction of new products while ensuring safety and efficacy.

Underlying macroeconomic factors: The Drug Delivery Devices Market within the Medical Devices sector is significantly influenced by macroeconomic factors such as healthcare spending, technological advancements, and demographic shifts. In Canada, robust national healthcare funding supports innovation and accessibility, fostering demand for advanced drug delivery systems. Conversely, Mexico's economic challenges may limit public investment, necessitating private sector engagement to enhance market growth. Furthermore, the broader North American market benefits from collaborative regulatory frameworks that facilitate cross-border trade, ensuring the availability of cutting-edge devices while maintaining high safety standards. Global economic trends, including rising healthcare costs and an increasing prevalence of chronic conditions, further drive the need for effective drug delivery solutions across the region.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

Explore more high-quality data on related topic

Medical technology industry - statistics & facts

Medical technology plays a role in the lives of everyone. It includes most of all, medical devices which simplify the prevention, diagnosis, and treatment of diseases and illnesses. The most well-known medical technology products are, among others, pacemakers, imaging instruments, dialysis machines, and implants. The global medical technology industry was worth over 567 billion U.S. dollars annually. Established centers of this industry include North America and Western Europe. The United States is home to the world’s largest medical technology companies. As of 2022, Abbott Laboratories had the largest global revenue at over 31.2 billion U.S. dollars. The main focus of devices manufactured by the Chicago-based company are diagnostics, cardiovascular, and diabetes care. Two other medtech companies that round off the top three largest companies –Medtronic and Johnson & Johnson – are both based in the United States. Although, industry trends show that Asia, and in particular China, is about to play a more prominent role in the years to come.